About this Journal Submit a Manuscript Table of Contents
ISRN Urology
Volume 2012 (2012), Article ID 379081, 7 pages
http://dx.doi.org/10.5402/2012/379081
Clinical Study

Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer

1Molecular and Immunological Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Department of Clinical Pathology and Clinical Genetics, County Council of Östergötland, 581 85 Linköping, Sweden
2Regional Cancer Centre, County Council of Östergötland, Linköping, Sweden
3Division of Urology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Department of Urology, County Council of Östergötland, Linköping, Sweden

Received 3 September 2012; Accepted 17 October 2012

Academic Editors: J. I. Izawa, T. Nelius, and V. Serretta

Copyright © 2012 Hans Olsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hans Olsson, Per Hultman, Nastaran Monsef, Johan Rosell, and Staffan Jahnson, “Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer,” ISRN Urology, vol. 2012, Article ID 379081, 7 pages, 2012. doi:10.5402/2012/379081